BioSpace News Archive

Biotech Beach

Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor

Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system.

August 23, 2023
·
9 min read
Pharm Country

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

The National Comprehensive Cancer Network® —a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer.

August 23, 2023
·
7 min read
Pharm Country

FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition

FORE Biotherapeutics today announced the closing of its $75 million Series D financing.

August 23, 2023
·
4 min read
Drug Development

Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies

Longboard Pharmaceuticals, Inc. today announced that it has completed enrollment of its Phase 1b/2a clinical trial, the PACIFIC Study, which is evaluating LP352, an oral, centrally acting 5-HT2C receptor superagonist, in 52 participants with Developmental and Epileptic Encephalopathies (DEEs).

August 23, 2023
·
8 min read
Biotech Beach

Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study

Amprion has been contracted by the National Institutes of Health Intramural Research Program’s Center for Alzheimer’s and Related Dementias to study the levels of misfolded alpha-synuclein proteins in people with Alzheimer’s disease.

August 23, 2023
·
4 min read
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13

Altamira Therapeutics Ltd. today announced that its founder, Chairman, and CEO Thomas Meyer will be presenting at the H.C. Wainwright 25th Annual Global Investment Conference, being held virtually and in person on September 11-13, 2023, at Lotte New York Palace Hotel in New York City.

August 23, 2023
·
4 min read
Business

FYR DIAGNOSTICS WELCOMES DR. NIALL LENNON AND DR. RYAN WALTERS TO ITS SCIENTIFIC ADVISORY BOARD

FYR Diagnostics , an emerging company developing liquid biopsy technologies for the diagnosis of cancer and neurodegenerative diseases, is pleased to welcome Dr. Niall Lennon and Dr. Ryan Walters to its Scientific Advisory Board (SAB).

August 23, 2023
·
3 min read
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy

Australian biotech company Ferronova announced today that it has signed a licensing agreement with the Purdue Research Foundation (PRF) for the application of PRF’s patented Fibroblast Activation Protein (FAP) inhibitor in magnetic resonance imaging (MRI) and MRI-guided therapies.

August 23, 2023
·
5 min read
Genetown

Comanche Biopharma Drug Receives FDA Fast Track Designation

Comanche Biopharma Corp. today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the investigation of Comanche’s asset CBP-4888 as a novel siRNA therapy for preeclampsia.

August 23, 2023
·
4 min read
Biotech Bay

Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting

Peak Bio, Inc. (“Peak Bio” or the “Company”) (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory orphan/rare diseases.

August 23, 2023
·
7 min read